• Home
  • NEW DAY MEDICINE
  • 1 (51) 2023
  • 26 -1 (51) 2023 — Khasanova G.S. Rakhmonova G.Sh. — EVALUATION OF CLINICAL COMPLAINTS IN PEOPLE WITH VARIOUS MANIFESTATIONS OF THE METABOLIC SYNDROME

26 -1 (51) 2023 — Khasanova G.S. Rakhmonova G.Sh. — EVALUATION OF CLINICAL COMPLAINTS IN PEOPLE WITH VARIOUS MANIFESTATIONS OF THE METABOLIC SYNDROME

EVALUATION OF CLINICAL COMPLAINTS IN PEOPLE WITH VARIOUS MANIFESTATIONS OF THE METABOLIC SYNDROME

Khasanova G.S. Tashkent Pediatric Medical Institute; Gulistan State University.

Rakhmonova G.Sh., Tashkent Pediatric Medical Institute;

Abdiev I.A., Termez branch of Tashkent Medical Academy;

Khalilova A.Sh., Tashkent Pediatric Medical Institute;

Aikhodzhaeva M.A., Republican Specialized Scientific and Practical Medical Center Endocrinology named after academician Ya.Kh. Turakulov;

Maksutova N.N., Republican Specialized Scientific and Practical Medical Center Endocrinology named after academician Ya.Kh. Turakulov;

Shamansurova Z.M.Tashkent Pediatric Medical Institute; Institute of Biophysics and Biochemistry at the National University of Uzbekistan;

Resume

In the article, authors compared clinical complaints, anthropometric, biochemical parameters in 248 patients with various manifestations of the metabolic syndrome (MetS), such as obesity, impaired glucose tolerance (IGT), polycystic ovary syndrome (PCOS), type 2 diabetes mellitus (DM2). The age of patients was important as a risk factor for the development of various manifestations of MetS. In particular, patients with PCOS were the youngest, and in the direction of obesity, IGT and DM2 the age were getting older. The body mass index was higher in all patients with MetS, which indicated higher body weight in all groups. In particular, BMI was highest in the obesity group (42.83 kg/m2), followed by IGT (36 kg/m2), PCOS (34.6 kg/m2), DM2 (32.34 kg/m2). Analysis of patients’ complaints made it possible to identify those that specific for manifestation forms of MetS. In particular, for DM2 the presence of dry mouse, thirst, frequent urination, weakness, dry skin were specific, whereas excessive food intake, weight gain, dyspnea were shown in IGT and obesity, excessive skin hairiness, infertility, menstrual cycle irregularities are more pronounced in PCOS, that could facilitate the identification and differential diagnosis of type of MetS manifestation in overweight or obese individuals in medical practice.

Keywords: people with metabolic syndrome, obesity, glucose intolerance, polycystic ovary syndrome.

First page

152

Last page

158

For citation: Khasanova G.S. Rakhmonova G.Sh., Abdiev I.A., Khalilova A.Sh., Aikhodzhaeva M.A., Maksutova N.N., Shamansurova Z.M. – EVALUATION OF CLINICAL COMPLAINTS IN PEOPLE WITH VARIOUS MANIFESTATIONS OF THE METABOLIC SYNDROME //New Day in Medicine 1(51)2023 152-158 https://clck.ru/33MVkS

LIST OF REFERENCES:

  1. Акбаров З.С., Шамансурова З.М., Алиханова Н.М., Каюмова Д., Ахмедова М.Х. Метаболический синдром – как ранний этап развития сахарного диабета. //Проблемы биологии и медицины. 2005; 2:30-33.
  2. Дедов И.И., Бутрова С.А., Синдром поликистозных яичников и метаболический синдром. //Ожирение и метаболизм 1.  2006.
  3. Жураева Х.И., Очилова Д.А., Кудратова Д.Ш. Распространенность и выявляемость сахарного диабета среди женского населения //Биология и интегративная медицина 2016; 2:80-87.
  4. Либис Р.А., Исаева Е. Н. Возможность применения индекса висцерального ожирения в диагностике метаболического синдрома и прогнозировании риска его осложнений //Российский кардиологический журнал 2014; 9(113): 48–53
  5. Шипова Н.С. Применение методики «Краткий опросник воз для оценки качества жизни» в исследовании лиц с ограниченными возможностями здоровья. //Педагогика. Психология. Социокинетика № 4, 2018.
  6. Alberti K.G., Eckel R.H., Grundy S.M. et al. Harmonizing the metabolic syndrome: a joint interim statement of  the  International  Diabetes  Federation  Task  Force on  Epidemiology  and  Prevention;  National  Heart, Lung, and Blood Institute; American Heart Association;  World  Heart  Federation;  International  Atherosclerosis Society; and International Association for the Study of Obesity //Circulation. 2009. Vol. 120. № 16. P. 1640–1645.
  7. Amato  M.C.,  Giordano  C.,  Galla  M.  et  al.  Visceral  adiposity  index.  A  reliable  indicator  of visceral fat function associated with cardiometabolic risk. //Diabetes care. 33(4), 2010.
  8. Amato  M.C.,  Giordano C. Clinical  indications  and  proper  use  of  visceral  adiposity  index. //Nutrition, Metabolism and Cardiovascular disease 2013; 23:31–2.
  9. Apridonidze T., Essah P. A., Iuorno M. J. et al. Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome //J Clin Endocrinol 2004; 10:1210/jc 2004-1045
  10. Bloomgarden  Z.T.  Symposium:  Debating the Metabolic Syndrome. Medscape Conference Coverage, based on selected sessions //American Diabetes Association 66th Scientific Sessions; June 9–13, 2006, Washington, DC
  11. Ma X. Metabolic syndrome in the prevention of cardiovascular diseases  and  diabetes  —  still  a  matter  of  debate? / X. Ma., S. Zhu //European Journal of Clinical Nutrition. 2013; Vol. 67, № 5.- P. 518-521.
  12. Povel C.M. Metabolic syndrome model definitions predicting type 2 diabetes and cardiovascular disease / C.M. Povel [et al.]//Diabetes Care.-2013.- Vol. 36, № 2.- P. 362-368.
  13. Saklayen M.G. The Global Epidemic of the Metabolic Syndrome. //Curr Hypertens Rep. 2018; 20(2):12. doi:10.1007/s11906-018-0812-z.
  14. Sherling D.H., Perumareddi P., Hennekens C.H. Metabolic Syndrome. //J Cardiovasc Pharmacol Ther. 2017; 22(4):365-7. doi:10.1177/1074248416686187.
  15. Son M., Seo J., Yang S. Association between dyslipidemia and serum uric acid levels in Korean adults: Korea National Health and Nutrition Examination Survey 2016-2017. //PLoS  One. 2020; 15(2):e0228684. doi:10.1371/journal.pone.0228684.
  16. Wang H., Zhang H., Sun L. et al. Roles of hyperuricemia in metabolic syndrome and cardiac-kidney-vascular system diseases. //Am J Transl Res. 2018;10(9):2749-63. eCollection 2018.
  17. WHOQOL: Measuring Quality of Life.  https://www.who.int/tools/whoqol/whoqol-bref/docs/default-source/publishing-policies/whoqol-bref/russian-whoqol-bref
  18. Xu D. The angiographic and clinical outcomes after coronary stenting in patients with metabolic syndrome / D. Xu [et al.] //Atherosclerosis. 2012; Vol. 221. P:416-421.

file

download